Background: Insulin resistance and lipid changes are commonly seen after ART initiation. Observational studies suggest that vitamin D supplementation reduces the risk of developing diabetes and improves lipid profiles.
Methods: This 48-week prospective, randomized, double-blind, placebo-controlled study evaluated the effect of high dose vitamin D3 (4000 IU daily) plus calcium supplementation (1000 mg calcium carbonate daily) in HIV-infected subjects initiating ART with efavirenz/emtricitabine/tenofovir. In this secondary analysis, changes in insulin resistance (as measured by HOMA-IR), lipid profile, and components of the metabolic syndrome were assessed at baseline, 24 and 48 weeks using the intent-to-treat approach. Stratified Wilcoxon rank sum tests and stratified normal score tests were used to test for differences between the two treatment groups, stratified by screening 25-OH vitamin D stratum (≤/> 20 ng/mL). A more conservative significance level 0.01 was used in order to adjust for multiple testing.
Results: 165 eligible subjects enrolled, with 79 in Vitamin D/Calcium (Vit D/Cal) group and 86 in placebo group. The placebo group but not the VitD/Cal group experienced modest increase in insulin resistance at week 24 (P<0.001). While increases in total and HDL cholesterol were apparent in both groups at weeks 24 and 48, increases in LDL cholesterol at week 24 were only marginal in the placebo group (P=0.011). BMI was stable over the course of the study, whereas modest increases in waist circumference were observed at week 24 that were not persistent at week 48. Metabolic syndrome was present in 19 subjects (12%) at baseline and 20 subjects (14%) at week 48 without differences between groups. There were no between group differences in any of these metabolic parameters at either 24 or 48 week evaluations (P≥0.17).
Conclusions: Vit D/Cal supplementation over 48 weeks did not attenuate increases in insulin resistance with initiation of efavirenz/emtricitabine/tenofovir in ART-naïve persons. The prevalence of metabolic syndrome did not increase significantly over the course of follow up. Vitamin D supplementation had minimal impact on metabolic parameters with ART initiation.